C4 Therapeutics CCCC Balance Sheet (2019-2026)

NASDAQ CCCC
$3.13 +0.02 (+0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

C4 Therapeutics Quarterly Balance Sheet

Periods 28 quarters
Latest Jun 2026

C4 Therapeutics reported total assets of $359.40M and total liabilities of $112.14M for the quarter ended Jun 2026, up 21.2% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
162.75M76.12M46.00M57.30M49.55M29.75M49.48M44.88M60.97M126.59M89.66M73.11M59.65M55.50M51.29M78.16M58.81M74.60M61.27M78.61M
Short-term InvestmentsInvestments (Current)
239.33M233.16M245.17M250.48M264.10M246.40M220.85M222.40M155.60M127.09M168.53M190.98M195.99M189.41M163.79M136.40M133.07M173.93M174.40M175.05M
Cash & Current Investments
402.07M309.28M291.17M307.78M313.65M276.15M270.32M267.29M216.57M253.68M258.19M264.10M255.64M244.90M215.09M214.55M191.88M248.54M235.67M253.66M
Receivables - NetNet Receivables
4.84M5.72M1.77M1.71M1.49M1.47M0.53M1.03M0.50M11.80M13.60M1.17M10.34M3.10M8.03M2.16M6.54M2.40M2.88M1.33M
Receivables
4.84M5.72M1.77M1.71M1.49M1.47M0.53M1.03M0.50M11.80M13.60M1.17M10.34M3.10M8.03M2.16M6.54M2.40M2.88M1.33M
Prepaid Assets
5.38M10.69M10.00M8.88M10.31M9.93M7.60M6.07M6.62M5.71M7.80M10.78M7.25M9.76M9.42M8.02M8.44M7.17M6.82M7.91M
Current Assets
412.29M325.69M302.95M318.37M325.46M287.56M278.45M274.39M223.69M271.19M279.59M276.04M273.23M257.77M232.53M224.73M206.86M258.11M245.37M262.90M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
3.32M3.11M3.03M6.34M7.42M7.40M7.64M7.57M7.29M7.13M6.76M6.57M6.21M5.84M5.48M5.54M5.13M4.74M4.49M4.15M
Long-Term Investments
78.19M142.20M130.48M90.06M52.36M60.96M34.71M19.41M29.86M28.01M40.98M31.64M28.76M22.36M19.62M8.42M7.88M48.56M32.60M46.79M
Other Non-Current Assets
1.28M3.28M3.28M3.28M3.28M3.28M3.36M3.29M3.45M3.44M5.23M3.44M5.26M3.44M3.44M3.44M3.44M3.68M3.87M4.49M
Non-Current Assets
95.62M181.08M212.54M174.11M135.98M143.28M117.58M100.62M109.33M105.26M118.78M105.05M102.83M91.83M86.99M71.80M58.62M100.97M83.49M96.50M
Assets
507.91M506.76M515.49M492.48M461.44M430.84M396.04M375.01M333.01M376.45M398.37M381.09M376.06M349.60M319.52M296.53M265.49M359.07M328.86M359.40M
Liabilities
Current Liabilities
Accounts Payables
3.75M4.51M3.40M4.45M2.37M1.17M1.03M2.25M1.28M1.45M1.63M0.91M1.50M1.33M0.68M2.22M1.33M0.86M0.77M1.12M
Payables
3.75M4.51M3.40M4.45M2.37M1.17M1.03M2.25M1.28M1.45M1.63M0.91M1.50M1.33M0.68M2.22M1.33M0.86M0.77M1.12M
Accumulated Expenses
11.47M13.61M9.84M16.96M17.94M19.77M16.30M16.73M15.48M20.63M12.89M11.20M15.39M19.36M12.63M13.55M11.27M13.31M9.83M13.79M
Other Accumulated Expenses
0.20M0.41M0.31M
Short term Debt
0.75M0.75M2.25M2.29M2.29M10.34M
Current Deferred Revenue
32.29M31.80M31.27M22.17M18.13M16.62M14.94M13.97M8.42M15.47M35.14M36.59M20.77M18.71M21.59M22.62M17.13M12.49M10.12M26.66M
Total Current Liabilities
48.69M51.25M46.99M46.15M45.27M44.55M39.38M48.24M30.27M42.77M55.02M54.20M43.29M45.18M40.82M44.46M35.95M33.03M27.25M48.25M
Non-Current Liabilities
Non-Current Debt
10.59M10.77M10.19M10.37M9.05M9.20M8.62M
Non-Current Deffered Revenue
38.94M24.37M19.02M17.99M16.77M16.89M15.85M24.65M19.62M21.81M20.71M16.91M28.65M28.46M25.12M21.15M19.89M15.84M15.44M13.71M
Preferred Stock Liabilities
Operating Leases
10.92M30.78M74.75M73.37M72.18M70.97M69.72M68.42M67.09M65.76M64.36M62.92M61.46M59.98M58.45M56.86M55.25M53.62M51.92M50.18M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
109.13M117.16M150.96M147.88M143.26M141.61M133.57M141.30M116.99M130.34M140.09M134.03M133.40M133.62M124.38M122.46M111.08M102.49M94.61M112.14M
Shareholder's Equity
Total Debt
10.59M10.77M10.94M11.12M11.30M11.48M10.91M10.34M
Common Equity
398.78M389.61M364.53M344.59M318.18M289.23M262.47M233.71M216.02M246.11M258.28M247.06M242.66M215.99M195.14M174.06M154.41M256.59M234.25M247.26M
Liabilities and Shareholders Equity
507.91M506.76M515.49M492.48M461.44M430.84M396.04M375.01M333.01M376.45M398.37M381.09M376.06M349.60M319.52M296.53M265.49M359.07M328.86M359.40M
Retained Earnings
-252.10M-267.71M-299.33M-326.75M-358.70M-395.89M-430.70M-466.60M-493.63M-528.38M-556.74M-574.50M-599.13M-633.70M-660.02M-686.04M-718.21M-738.69M-763.82M-787.50M

C4 Therapeutics Balance Sheet API

Pull C4 Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CCCC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY